EUVIMEDEUVIMED entdecken
Crossref

A Self‐Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple‐Negative Breast Cancer

Xianquan Feng iD, Yan Zhang, Wanjing Lin, Jing Li, Fei Wu, Qingyu Lu, Hongtao Song, Hao Zhang, Fenghua Lan, Jun Lu

Small · 2025

DOI: 10.1002/smll.202410214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Xianquan Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Transplant Biology, Laboratory of Basic Medicine, Fuzong Clinical College of Fujian Medical University (900th Hos…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Photochemotherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Scientific Startup Foundation of Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of immunotherapy in triple‐negative breast cancer (TNBC) is significantly hindered by its low immunogenicity and immunosuppressive tumor microenvironment. Non‐invasive photodynamic therapy (PDT) is increasingly recognized as a potential immunotherapeutic stimulant in the treatment of TNBC. However, photodynamic immunotherapy is constrained by tumor hypoxia and excessive inflammation suppression during the course of treatment. Herein, a simple and efficacious biomedicine is formulated to overcome adverse influences by amplifying photodynamic immunotherapy, thereby stimulating the systemic immune response. Specifically, the approach targeted tumor delivery by employing specific agents such as the photosensitizer (verteporfin), the hypoxic ameliorator (atovaquone), and the cyclooxygenase‐2/prostaglandin E2 (COX‐2/PGE2) signaling blocker (celecoxib). More importantly, the biomedicine effectively ameliorated hypoxia and inhibited COX‐2/PGE2 signaling, thereby amplifying PDT‐induced immunogenic cell death. This, in turn, enhanced the efficacy of photodynamic immunotherapy and triggered a robust immune response cascade. Notably, the self‐amplifying photodynamic biomedicine significantly inhibited primary tumors, distal tumors, lung metastases, and post‐operative recurrence while maintaining high biocompatibility. To sum up, the work provides a viable cascade stimulation approach and an efficient biomedical nanoplatform, offering a novel strategy for photodynamic immunotherapy of TNBC in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPhotochemotherapyHumansAnimalsFemaleCell Line, TumorPhotosensitizing AgentsImmunotherapyMice

Stichwörter der Autor:innen

COX‐2/PGE2cascade immune activationhypoxiaphotodynamic immunotherapytriple‐negative breast cancer

Substanzen

Photosensitizing Agents

Autor:innen und Institutionen

  • Fujian Provincial Key Laboratory of Transplant Biology, Laboratory of Basic Medicine, Fuzong Clinical College of Fujian Medical University (900th Hospital of the Joint Logistics Support Force), Fuzhou, 350025, China.
  • Department of Oncology, Fuzong Clinical College of Fujian Medical University (900th Hospital of the Joint Logistics Support Force), Fuzhou, 350025, China.
  • Department of Pharmacy, Fuzong Clinical College of Fujian Medical University (900th Hospital of the Joint Logistics Support Force), Fuzhou, 350025, China.

ORCID-Profile: Xianquan Feng

Förderung

  • Natural Science Foundation of Fujian Province
  • Scientific Startup Foundation of Fujian Medical University

Zitieren

APA

Feng, X., Zhang, Y., Lin, W., Li, J., Wu, F., Lu, Q., Song, H., Zhang, H., Lan, F., & Lu, J. (2025). A Self‐Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple‐Negative Breast Cancer. Small. https://doi.org/10.1002/smll.202410214

Vancouver

Feng X, Zhang Y, Lin W, Li J, Wu F, Lu Q, et al. A Self‐Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple‐Negative Breast Cancer. Small. 2025. doi:10.1002/smll.202410214

BibTeX
@article{Feng2025,
  author = {Feng, Xianquan and Zhang, Yan and Lin, Wanjing and Li, Jing and Wu, Fei and Lu, Qingyu and Song, Hongtao and Zhang, Hao and Lan, Fenghua and Lu, Jun},
  title = {A Self‐Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple‐Negative Breast Cancer},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202410214}
}
Kostenlos starten →